Welcome to DukeHealth.org.
Skip over navigation
  • Home
  • Patient and Visitor Info
  • Physicians
  • Services
  • Clinical Trials
  • Event Calendar
  • Locations
  • Health Library
  • About Duke Medicine

Quick Links

  • Appointments
  • HealthView Patient Login
  • Quality and Safety
Home > Physicians > March, John S.
Jumbo Large Regular Text:
Print
Physicians

John S. March, MD, MPH

Related Content

Services

  • Psychiatry

Health Library

  • Nearly All Depressed Adolescents Recover with Treatment, But Half Relapse

Share

John S. March, MD, MPH

Division of Neurosciences Medicine, Duke Clinical Research Institute

Department / Division
Psychiatry / Child & Adolescent Psychiatry

Address
DUMC 3850
Durham, NC 27710

Appointment Telephone
919-681-1100

Office Telephone
919-668-4644

Fax Telephone
919-668-7056

Training
  • MD, MPH, University of California–Los Angeles David Geffen School of Medicine, 1978

Residency
  • Family Practice, University of California–Los Angeles, 1978-1981
  • Psychiatry, University of Wisconsin Health, 1986-1988

Fellowship
  • Child Psychiatry, University of Wisconsin Health, 1988-1990

Clinical Interests
Clinical trials in adult and pediatric neurology, psychiatry, and pain; pediatric psychopharmacology, intervention, biomarkers/biosignatures

Research Interests
Dr. March is Professor of Psychiatry and Psychology and Director of the Division of Neurosciences Medicine at the Duke Clinical Research Institute. Dr. March develops, conducts and facilitates research projects in adult and child neurology and psychiatry that range from biomarker/biosignature development and validation, imaging genomics, Phase I-IV industry and Federal clinical trials, to outcomes research.

Industry Relationships and Collaborations (What's this?)

This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.

  • Bristol-Myers Squibb
  • Eli Lilly & Co.
  • Guilford Publications
  • Multi-Health Systems Inc.
  • Pfizer Inc.
  • Shire Pharmaceuticals

Representative Publications
March, JS; Fegert, JM. Drug development in pediatric psychiatry: current status, future trends. Child and Adolescent Psychiatry and Mental Health. 2012;6:7. (2012) Abstract

Franklin, ME; Sapyta, J; Freeman, JB; Khanna, M; Compton, S; Almirall, D; Moore, P; Choate-Summers, M; Garcia, A; Edson, AL; Foa, EB; March, JS. Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial. JAMA: Journal of the American Medical Association. 2011;306:1224-1232. (2011) Abstract

Kratochvil, CJ; Vaughan, BS; Stoner, JA; Daughton, JM; Lubberstedt, BD; Murray, DW; Chrisman, AK; Faircloth, MA; Itchon-Ramos, NB; Kollins, SH; Maayan, LA; Greenhill, LL; Kotler, LA; Fried, J; March, JS. A double-blind, placebo-controlled study of atomoxetine in young children with ADHD. Pediatrics. 2011;127:e862-e868. (2011) Abstract

Leckman, JF; March, JS. Editorial: Developmental neuroscience comes of age. Journal of Child Psychology and Psychiatry. 2011;52:333-338. (2011) Abstract

March, JS. Looking to the future of research in pediatric anxiety disorders. Depression and Anxiety. 2011;28:88-98. (2011) Abstract

March, JS. The preschool ADHD Treatment Study (PATS) as the culmination of twenty years of clinical trials in pediatric psychopharmacology. Journal of the American Academy of Child and Adolescent Psychiatry. 2011;50:427-430. (2011) Abstract

March, JS. Attention bias modification training and the new interventions research. Biological Psychiatry. 2010;68:978-979. (2010) Abstract

March, JS. Commentary on 'Forum: use of antidepressants in children and adolescents'. Current Opinion in Psychiatry. 2010;23:63-65. (2010) Abstract

Brent, DA; Greenhill, LL; Compton, S; Emslie, G; Wells, K; Walkup, JT; Vitiello, B; Bukstein, O; Stanley, B; Posner, K; Kennard, BD; Cwik, MF; Wagner, A; Coffey, B; March, JS; Riddle, M; Goldstein, T; Curry, J; Barnett, S; Capasso, L; Zelazny, J; Hughes, J; Shen, S; Gugga, SS; Turner, JB. The Treatment of Adolescent Suicide Attempters study (TASA): predictors of suicidal events in an open treatment trial. Journal of the American Academy of Child and Adolescent Psychiatry. 2009;48:987-996. (2009) Abstract

March, JS. The future of psychotherapy for mentally ill children and adolescents. Journal of Child Psychology and Psychiatry. 2009;50:170-179. (2009) Abstract

March, JS; Vitiello, B. Benefits exceed risks of newer antidepressant medications in youth--maybe. Clinical Pharmacology and Therapeutics. 2009;86:355-357. (2009) Abstract

March, JS; Vitiello, B. Clinical messages from the Treatment for Adolescents With Depression Study (TADS). American Journal of Psychiatry. 2009;166:1118-1123. (2009) Abstract

Shapiro, M; Silva, SG; Compton, S; Chrisman, A; DeVeaugh-Geiss, J; Breland-Noble, A; Kondo, D; Kirchner, J; March, JS. The child and adolescent psychiatry trials network (CAPTN): infrastructure development and lessons learned. Child and Adolescent Psychiatry and Mental Health. 2009;3:12. (2009) Abstract

Vitiello, B; Silva, SG; Rohde, P; Kratochvil, CJ; Kennard, BD; Reinecke, MA; Mayes, TL; Posner, K; May, DE; March, JS. Suicidal events in the Treatment for Adolescents With Depression Study (TADS). Journal of Clinical Psychiatry. 2009;70:741-747. (2009) Abstract

Krystal, JH; Carter, CS; Geschwind, D; Manji, HK; March, JS; Nestler, EJ; Zubieta, JK; Charney, DS; Goldman, D; Gur, RE; Lieberman, JA; Roy-Byrne, P; Rubinow, DR; Anderson, SA; Barondes, S; Berman, KF; Blair, J; Braff, DL; Brown, ES; Calabrese, JR; Carlezon, WA; Cook, EH; Davidson, RJ; Davis, M; Desimone, R; Drevets, WC; Duman, RS; Essock, SM; Faraone, SV; Freedman, R; Friston, KJ; Gelernter, J; Geller, B; Gill, M; Gould, E; Grace, AA; Grillon, C; Gueorguieva, R; Hariri, AR; Innis, RB; Jones, EG; Kleinman, JE; Koob, GF; Krystal, AD; Leibenluft, E; Levinson, DF; Levitt, PR; Lewis, DA; Liberzon, I; Lipska, BK; Marder, SR; Markou, A; Mason, GF; McDougle, CJ; McEwen, BS; McMahon, FJ; Meaney, MJ; Meltzer, HY; Merikangas, KR; Meyer-Lindenberg, A; Mirnics, K; Monteggia, LM; Neumeister, A; O'Brien. . . It is time to take a stand for medical research and against terrorism targeting medical scientists. Biological Psychiatry. 2008;63:725-727. (2008) Abstract

Rohde, P; Silva, SG; Tonev, ST; Kennard, BD; Vitiello, B; Kratochvil, CJ; Reinecke, MA; Curry, JF; Simons, AD; March, JS. Achievement and maintenance of sustained response during the Treatment for Adolescents With Depression Study continuation and maintenance therapy. Archives of General Psychiatry. 2008;65:447-455. (2008) Abstract

Walkup, JT; Albano, AM; Piacentini, J; Birmaher, B; Compton, SN; Sherrill, JT; Ginsburg, GS; Rynn, MA; McCracken, J; Waslick, B; Iyengar, S; March, JS; Kendall, PC. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. New England Journal of Medicine. 2008;359:2753-2766. (2008) Abstract

Compton, SN; Kratochvil, CJ; March, JS. Pharmacotherapy for anxiety disorders in children and adolescents: an evidence-based medicine review. Pediatric Annals: a journal of continuing pediatric education. 2007;36:586-598. (2007) Abstract

Kollins, SH; March, JS. Advances in the pharmacotherapy of attention-deficit/hyperactivity disorder. Biological Psychiatry. 2007;62:951-953. (2007) Abstract

March, JS; Entusah, AR; Rynn, M; Albano, AM; Tourian, KA. A Randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder. Biological Psychiatry. 2007;62:1149-1154. (2007) Abstract

March, JS; Franklin, ME; Leonard, H; Garcia, A; Moore, P; Freeman, J; Foa, E. Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder. Biological Psychiatry. 2007;61:344-347. (2007) Abstract

March, JS; Silva, S; Petrycki, S; Curry, J; Wells, K; Fairbank, J; Burns, B; Domino, M; McNulty, S; Vitiello, B; Severe, J. The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes. Archives of General Psychiatry. 2007;64:1132-1143. (2007) Abstract

March, JS; Szatmari, P; Bukstein, O; Chrisman, A; Kondo, D; Hamilton, JD; Kremer, CM; Kratochvil, CJ. AACAP 2005 Research Forum: speeding the adoption of evidence-based practice in pediatric psychiatry. Journal of the American Academy of Child and Adolescent Psychiatry. 2007;46:1098-1110. (2007) Abstract

March, JS; Klee, BJ; Kremer, CM. Treatment benefit and the risk of suicidality in multicenter, randomized, controlled trials of sertraline in children and adolescents. Journal of Child and Adolescent Psychopharmacology. 2006;16:91-102. (2006) Abstract

March, JS; Chrisman, A; Breland-Noble, A; Clouse, K; D'Alli, R; Egger, H; Gammon, P; Gazzola, M; Lin, A; Mauro, C; Rana, A; Ravi, H; Srirama, M; Su, H; Thrall, G; van de Velde, P; Duke Pediatric Psychiatry EBM Seminar Team. Using and teaching evidence-based medicine: the Duke University child and adolescent psychiatry model. Child and Adolescent Psychiatric Clinics of North America. 2005;14:273-ix. (2005) Abstract

March, JS; Silva, SG; Compton, S; Shapiro, M; Califf, R; Krishnan, R. The case for practical clinical trials in psychiatry. American Journal of Psychiatry. 2005;162:836-846. (2005) Abstract

March, JS; Silva, SG; Compton, S; Anthony, G; DeVeaugh-Geiss, J; Califf, R; Krishnan, R. The Child and Adolescent Psychiatry Trials Network (CAPTN). Journal of the American Academy of Child and Adolescent Psychiatry. 2004;43:515-518. (2004) Abstract

Greenhill, LL; Vitiello, B; Abikoff, H; Levine, J; March, JS; Riddle, MA; Capasso, L; Cooper, TB; Davies, M; Fisher, P; Findling, RL; Fried, J; Labellarte, MJ; McCracken, JT; McMahon, D; Robinson, J; Skrobala, A; Scahill, L; Varipatis, E; Walkup, JT; Zito, JM. Developing methodologies for monitoring long-term safety of psychotropic medications in children: report on the NIMH conference, September 25, 2000. Journal of the American Academy of Child and Adolescent Psychiatry. 2003;42:651-655. (2003) Abstract

Greenhill, LL; Vitiello, B; Riddle, MA; Fisher, P; Shockey, E; March, JS; Levine, J; Fried, J; Abikoff, H; Zito, JM; McCracken, JT; Findling, RL; Robinson, J; Cooper, TB; Davies, M; Varipatis, E; Labellarte, MJ; Scahill, L; Walkup, JT; Capasso, L; Rosengarten, J. Review of safety assessment methods used in pediatric psychopharmacology. Journal of the American Academy of Child and Adolescent Psychiatry. 2003;42:627-633. (2003) Abstract

March, JS. Acute stress disorder in youth: a multivariate prediction model. Biological Psychiatry. 2003;53:809-816. (2003) Abstract

Costello, EJ; Pine, DS; Hammen, C; March, JS; Plotsky, PM; Weissman, MM; Biederman, J; Goldsmith, HH; Kaufman, J; Lewinsohn, PM; Hellander, M; Hoagwood, K; Koretz, DS; Nelson, CA; Leckman, JF. Development and natural history of mood disorders. Biological Psychiatry. 2002;52:529-542. (2002) Abstract

March, JS; Biederman, J; Wolkow, R; Safferman, A; Mardekian, J; Cook, EH; Cutler, NR; Dominguez, R; Ferguson, J; Muller, B; Riesenberg, R; Rosenthal, M; Sallee, FR; Wagner, KD; Steiner, H. Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial. JAMA: Journal of the American Medical Association. 1998;280:1752-1756. (1998) Abstract

Contact Us | Careers | Privacy Policy | Make a Gift | Site Map | RSS Feeds | En Español | Mobile Site | Help
Duke Medicine | Duke School of Medicine | Duke Children's | Duke University
Toll-Free: 888-ASK-DUKE (888-275-3853)
Copyright © 2004-2013 Duke University Health System

About This Page

Updated: Nov. 4, 2010
Published: Dec. 12, 2006
URL: http://www.dukehealth.org/physicians/john_s_march